Under-eye pigmentation — a patient-decision guide
Under-eye darkness is more complicated than it looks. What reads visually as "dark circles" reflects four quite different underlying mechanisms — true pigmentation in the under-eye skin, structural hollowing producing shadow, vascular shadowing through thin under-eye skin, and transient fatigue or fluid-related changes. Each responds to different interventions, and treatment effective for one cause has little effect on the others. This guide explains what each mechanism is, how the dermatologist distinguishes them, what evidence-based management looks like across the different patterns, and why Indian-skin Fitzpatrick III–VI considerations sit centrally.
What this guide does and does not do
This guide explains under-eye darkness at the principles level — the four common mechanisms, how the dermatologist distinguishes them, what evidence-based management looks like for each, and the central conservative posture for the under-eye zone in Indian skin. The aim is to help readers understand that "dark circles" is not one condition; an effective approach starts with distinguishing the dominant cause.
The guide does not provide a diagnosis or prescribe specific topical, filler, or procedural agents. Under-eye filler placement is a high-skill intervention with meaningful risks; appropriate practitioner selection matters substantially and not every patient is a candidate. The framework explicitly does not endorse informal "lightening" products applied to the under-eye zone, which carry meaningful steroid-related risk. For specific questions, a dermatologist consultation is the right next step.
The four mechanisms
True pigmentation is increased melanin in the periorbital skin itself. The skin is darker in colour at the histological level. It can be epidermal (more responsive to topical work), dermal (deeper, less responsive), or mixed. It is more common in Indian and broader Fitzpatrick III–VI skin and often runs in families. Drivers include sun exposure, friction from chronic eye-rubbing or eyebrow tweezing, post-inflammatory pigmentation from prior periorbital dermatitis, hormonal influence, and atopic-dermatitis history.
Structural hollowing is the tear-trough depression at the lid-cheek junction. The depression catches shadow and reads as darkness even when the skin colour is not pigmented. Hollowing reflects volume loss in the cheek-tissue, the orbital fat compartments, or both, and is partly genetic (visible from young age in some patients) and partly age-related. It does not respond to topical pigmentation work because the visual concern is shadow, not pigment.
Vascular shadowing reflects visible blood-vessel patterns showing through thin periorbital skin. Venous and capillary patterns produce a bluish or purplish appearance that reads as darkness. This is more pronounced in patients with naturally thin under-eye skin, with chronic allergic eye-rubbing producing thinning, and with prominent baseline vascularity. It does not respond to pigmentation treatment.
Fatigue and fluid changes produce transient changes — sleep deprivation, dehydration, alcohol, salt intake, allergic congestion, crying, and recent illness all temporarily darken or puff the under-eye zone. These are non-permanent and respond to addressing the underlying factor.
Most patients have a mix. The dermatologist's role at consultation is identifying the dominant mechanism (or mix) so the management plan addresses what is actually producing the appearance.
How the dermatologist distinguishes them
Through history (onset, family pattern, allergy and atopic history, chronic eye-rubbing or itching, sleep pattern, prior treatments and their effect), examination under appropriate light (looking at the colour of the skin itself versus the shadow cast versus visible vascular pattern), and selectively a stretch-test (pulling the under-eye skin gently — pigmentation persists with stretch, shadow reduces). Wood's lamp examination can support depth assessment for the pigmentation component. Some patients have early structural hollowing they have not noticed; many have stronger pigmentation than they realise; many have a vascular contribution they had attributed to fatigue. Identifying the actual mix is the foundation of useful treatment.
Treatment for true pigmentation
Pigmentation-specific topicals at appropriate concentrations and frequency, with under-eye safety considerations. The under-eye skin is thinner and more sensitive than facial skin elsewhere; concentrations and frequencies are typically lower. Hydroquinone in selected patients under dermatologist supervision (with the careful-use considerations from the broader hydroquinone framework). Tranexamic acid topical and selectively oral. Vitamin C, niacinamide, retinoids (where tolerated, with under-eye-specific care and barrier support), and other actives the dermatologist tailors.
Selectively procedural support has a role. Calibrated chemical peels at appropriate parameters support pigment-cell turnover. Certain Q-switched laser approaches at conservative parameters can support pigmentation fade in selected patients. Brightening protocols at evidence-based parameters add to the topical layer. Sun-protection extending into the under-eye zone is foundational; many patients miss the under-eye in their sun-protection routine, and ongoing exposure prevents fade. Combinations the dermatologist tailors typically outperform single-agent regimens.
Treatment for structural hollowing
Volumising approaches the dermatologist considers carefully. Under-eye filler placement (typically hyaluronic-acid-based filler at appropriate depth and volume) addresses the structural depression directly. This is one of the most technically demanding aesthetic-medicine interventions; complications include overcorrection (producing visible swelling that can persist for months and is difficult to fully reverse), tyndall effect (bluish discolouration through thin skin where filler is placed too superficially), prolonged swelling, post-injection bruising, and rare but serious vascular events.
The framework leans conservative — small volumes, appropriate placement depth, careful patient selection, and clear revision pathways including hyaluronidase if a hyaluronic-acid filler needs reversal. Some patients are not appropriate candidates for under-eye filler — patients with very thin under-eye skin prone to tyndall, patients with significant fluid retention prone to overcorrection swelling, patients with realistic concerns about repeated procedural maintenance. The consultation is honest about candidacy rather than pursuing inappropriate intervention. Volume-loss in the broader cheek-tissue is sometimes addressed before or instead of under-eye-specific filler. The under-eye hollowness guide covers structural considerations in depth.
Treatment for vascular shadowing
Vascular shadowing is the hardest of the four mechanisms to address directly. Selected light-based platforms can reduce visible vascularity in some patients but the response is variable and not always durable. More often the framework supports the surrounding skin (improving texture and reducing translucency), addresses contributing factors (allergy management to reduce rubbing-induced thinning, sleep, hydration), and accepts that some vascular component remains. Patients with significant vascular shadowing should arrive with calibrated expectations — improvement is often modest, and combination with pigmentation and structural work where present produces a better overall outcome than vascular-targeted intervention alone.
Treatment for fatigue and fluid contribution
Fatigue and fluid contributions respond to addressing the underlying factor. Sleep pattern improvement, hydration, allergy management, salt-intake reduction, and addressing nasal congestion all reduce transient under-eye darkening. These are not dermatology interventions; they are lifestyle and medical-management contributions to the picture. Patients with primarily fatigue-driven darkness sometimes pursue dermatology treatment for what would respond to addressing the underlying factor; the consultation is honest about this distinction. Persistent darkness with transient flares is common; the framework addresses both layers.
Indian-skin Fitzpatrick III–VI framing
Indian and broader Fitzpatrick III–VI skin shows higher prevalence of true under-eye pigmentation and a stronger pigmentation response to inflammation. Aggressive treatments calibrated for lighter skin can produce post-inflammatory pigmentation in the under-eye zone that is harder to manage than the original picture. The under-eye skin is delicate; conservative parameter selection across all modalities is the standard. Filler placement in Indian skin at appropriate depth avoids the tyndall effect through thin skin. The framework uses gentler topical sequencing, conservative procedural parameters, and substantial sun-protection support throughout. The Indian Skin Treatment Safety Guide covers broader Indian-skin considerations.
What worsens the picture
Continued unprotected ultraviolet exposure worsens pigmentation. Chronic eye-rubbing (often from undiagnosed allergy or atopic eye disease) drives both pigmentation and skin-thinning. Sleep deprivation flares fatigue contribution. Aggressive topical actives in the under-eye zone produce irritation and post-inflammatory pigmentation. Informal "lightening" creams in the under-eye zone are particularly risky — the thin permeable skin produces stronger steroid effect with corresponding rebound risk. Aggressive procedural work pushed without appropriate parameter calibration in darker skin can produce worse pigmentation than the starting point. Identifying and modifying these patterns is part of the long-term plan.
When to consult a dermatologist
Reasonable triggers for an under-eye consultation include: persistent darkness despite home routine; bothersome appearance affecting confidence or photographs; suspected mix of contributors that need clinical distinction; chronic eye-rubbing or allergic eye-itching that may be driving the picture; prior under-eye filler that has migrated or that needs reassessment; or simply the patient's decision to address persistent darkness rather than continuing to chase OTC products. Booking a dermatologist consultation is the appropriate first step.
Practical next steps
Photograph the under-eye zone in identical lighting in early-morning and end-of-day conditions, on multiple days — appearance varies. List all current under-eye products and any informal "lightening" products honestly. Note allergy history and any chronic eye-rubbing or eye-area itching. Note sleep pattern and recent fatigue. List prior under-eye treatments (filler, laser, peels) with timing. Bring honest expectations — under-eye work is gradual, structural and pigmentation contributions need separate pathways, and not every patient is a candidate for every intervention.
Safety, expectation, and honest framing
Under-eye work carries pathway-specific considerations. Filler placement carries overcorrection, tyndall, prolonged swelling, and rare vascular complications. Topical actives in the thin under-eye skin carry irritation and post-inflammatory pigmentation risk if pushed without barrier support. Procedural laser and peel work in the under-eye zone in Indian skin carries higher post-inflammatory pigmentation risk than facial skin elsewhere. Some patients are not appropriate candidates for under-eye filler; the consultation is honest about candidacy. The clinic does not commit to specific clearance percentages or fixed transformation. Calibrated expectations against the underlying mechanism produce the most useful experience.
Related pages and next reading
Frequently asked questions
Why is under-eye darkness more complicated than it looks?
Because what reads visually as "dark circles" reflects four quite different underlying mechanisms — true pigmentation in the under-eye skin, structural hollowing producing shadow, vascular shadowing through thin under-eye skin, and transient fatigue or fluid-related changes. Each responds to different interventions, and a treatment effective for one cause has little effect on the others. The dermatologist's diagnostic role at consultation is distinguishing the dominant cause (often a mix of two or three) so management is matched to the actual underlying picture.
What is true under-eye pigmentation?
True under-eye pigmentation is increased melanin in the periorbital skin itself. It can be epidermal (more responsive to topical work), dermal (deeper, less responsive), or mixed. It is more common in Indian and broader Fitzpatrick III–VI skin and often runs in families. Drivers include sun exposure, friction (rubbing the eyes, eyebrow tweezing, allergic eye-rubbing), post-inflammatory pigmentation from prior dermatitis, hormonal influence, and atopic-dermatitis history. Treatment uses pigmentation-specific topicals (with under-eye safety considerations) and selectively procedural support.
What is structural hollowing?
Structural hollowing is the tear-trough — a depression at the boundary of the lower eyelid skin and the cheek tissue. The depression catches shadow and reads visually as darkness even when the skin colour itself is not pigmented. Hollowing reflects volume loss in the cheek-tissue, in the orbital fat compartments, or both, and is partly genetic and partly age-related. It does not respond to pigmentation treatment (topicals, lasers) because the visual concern is shadow rather than pigment. Hollowing responds to volumising approaches the dermatologist considers carefully — under-eye filler placement is a specific, technically demanding intervention with meaningful risks and is not appropriate for every patient.
What is vascular shadowing?
Vascular shadowing reflects visible blood-vessel patterns showing through thin periorbital skin. The vessels — venous and capillary — produce a bluish or purplish appearance that reads as darkness. This is more pronounced in patients with naturally thin under-eye skin, in patients with chronic allergic eye-rubbing producing skin thinning, and in patients with prominent vascularity. Vascular shadowing does not respond to pigmentation treatment. Selected light-based platforms can reduce visible vascularity in some patients; more often the framework is supporting the surrounding skin and managing the contributing factors (allergy, rubbing, sleep) rather than directly targeting the vessels.
What about fatigue and fluid changes?
Sleep deprivation, dehydration, alcohol intake, salt intake, allergic congestion, and crying produce transient changes in under-eye appearance — a darker, puffier, or more shadowed look. These are non-permanent and respond to addressing the underlying factor (sleep, hydration, allergy management, salt reduction). Patients sometimes pursue dermatology treatment for what is actually a transient lifestyle pattern; the consultation distinguishes transient from persistent picture before treatment is considered. Persistent darkness with transient flares is common; the framework addresses both layers.
How does the dermatologist distinguish the causes?
Through history (onset, family pattern, allergy and atopic history, eye-rubbing pattern, sleep pattern, prior treatments and their effect), examination under appropriate light (looking at the colour itself versus shadow versus visible vascularity), and selectively a stretch-test (pulling the under-eye skin gently — pigmentation persists, shadow reduces). Wood's lamp examination can support depth assessment for the pigmentation component. Most patients have a mix of contributors, and the relative weights determine management.
What treatments work for true pigmentation?
Pigmentation-specific topicals at appropriate concentrations and frequency, with under-eye safety considerations. Hydroquinone in selected patients under dermatologist supervision (with the careful-use considerations that apply more broadly to hydroquinone). Tranexamic acid topical and selectively oral. Vitamin C, niacinamide, retinoids (where tolerated, with under-eye-specific care), and other actives the dermatologist tailors. Selectively procedural support — calibrated chemical peels at appropriate parameters, certain Q-switched laser approaches at conservative parameters, and brightening protocols. Sun-protection extending into the under-eye zone is foundational. Combinations the dermatologist tailors typically outperform single-agent regimens.
What treatments work for structural hollowing?
Volumising approaches the dermatologist considers carefully. Under-eye filler placement (typically hyaluronic-acid-based filler at appropriate depth and volume) addresses the structural depression directly. This is technically demanding — the under-eye is one of the highest-skill aesthetic medicine zones, with complications including overcorrection, tyndall effect (bluish discolouration through thin skin), prolonged swelling, and rare vascular complications. The dermatologist assesses suitability, sets calibrated expectations, and proceeds conservatively where appropriate. Some patients are not good candidates for under-eye filler and the framework reflects that. Volume-loss in the broader cheek-tissue is sometimes addressed before or instead of under-eye-specific filler.
What about fillers and side-effects?
Under-eye filler at appropriate placement and volume can reduce structural shadowing, but carries specific considerations. Overcorrection produces visible swelling that can persist for months and is difficult to fully reverse. Tyndall effect — bluish discolouration through thin skin where filler is placed too superficially — produces an outcome worse than the starting point. Prolonged swelling and post-injection bruising are common. Rare vascular complications (filler entering blood vessels) can produce serious tissue or vision-related events; this is why injector skill and anatomical understanding matter substantially. The framework leans conservative — small volumes, appropriate depth, careful patient selection, and revision pathways including hyaluronidase if a hyaluronic-acid filler needs reversal.
What about creams marketed for "dark circles"?
Most over-the-counter "dark circle" creams produce minimal effect on the dominant causes. Caffeine-containing products may produce mild transient brightening through vasoconstriction but do not address pigmentation, hollowing, or persistent vascular shadowing. Vitamin K, retinol, and peptide products at over-the-counter concentrations produce limited effect. Informal "lightening" creams in the under-eye zone are particularly risky — the skin is thin, more permeable, and more prone to steroid-induced changes than facial skin elsewhere. The framework here addresses under-eye darkness through dermatologist-supervised pathways rather than these products.
Why does Indian-skin context matter for under-eye work?
Indian and broader Fitzpatrick III–VI skin shows higher prevalence of true under-eye pigmentation and a stronger pigmentation response to inflammation. Aggressive treatments calibrated for lighter skin can produce post-inflammatory pigmentation in the under-eye zone that is harder to manage than the original picture. The under-eye skin is delicate; conservative parameter selection across all modalities is the standard. Filler placement in Indian skin at appropriate depth avoids the tyndall effect that produces visible discolouration. The framework calibrated for Indian skin uses gentler topical sequencing, conservative procedural parameters, and substantial sun-protection support.
What does an under-eye consultation cover?
A useful consultation includes detailed history (onset, family pattern, allergy and atopic history, eye-rubbing, sleep pattern, prior treatments), examination under appropriate light to distinguish pigmentation versus hollowing versus vascular versus fatigue contribution, stretch-testing where useful, skin-type categorisation, and proposed plan. The dermatologist identifies the dominant contributor (or mix), proposes a layered plan combining topical, structural where appropriate, and lifestyle layers, and sets calibrated expectations with realistic timeline framing. Some patients are not appropriate candidates for filler; the consultation is honest about this rather than pursuing inappropriate intervention.
Practical steps before an under-eye consultation
Photograph the under-eye zone in identical lighting, preferably in early morning and end-of-day conditions, on multiple days — appearance varies. List all current under-eye products and any informal "lightening" products honestly. Note allergy history and any chronic eye-rubbing or eye-area itching. Note sleep pattern and recent fatigue. List any prior under-eye treatments (filler, laser, peels) honestly with timing — prior filler that has migrated or that needs assessment is part of the picture. Bring honest expectations — under-eye work is gradual, structural and pigmentation contributions need separate pathways, and not every patient is a candidate for every intervention.
Is this guide medical advice?
No. This guide provides educational content about under-eye pigmentation and the broader dark-circle picture at the principles level. Filler placement, prescription topicals, and procedural work are dermatologist-led. The under-eye is a high-skill zone; appropriate practitioner selection matters substantially. The Medical Disclaimer describes scope and limits.
Book a dermatologist consultation
If under-eye darkness is the concern, the right next step is a dermatologist consultation where the contributing mechanisms can be distinguished and a plan structured around your specific picture, skin type, and candidacy.